文献速递类风湿关节炎

在类风湿关节炎发展过程中,跖骨间滑囊炎可能先于临床关节肿胀出现:一项针对临床疑似关节痛患者的大型影像学研究

During development of rheumatoid arthritis, intermetatarsal bursitis may occur before clinical joint swelling: a large imaging study in patients with clinically suspect arthralgia.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

研究对577例连续临床疑似关节痛(CSA)患者行足前部、掌指关节和腕关节的增强MRI,评估跖骨间滑囊炎(IMB)的发生率及预后价值。23%的CSA患者存在IMB,ACPA阳性者中更常见(47% vs 19%)。IMB与亚临床滑膜炎和腱鞘炎相关,并预测关节炎发展,尤其在ACPA阳性CSA患者中。

要点

  • 23%的临床疑似关节痛患者存在跖骨间滑囊炎,ACPA阳性者中占47%。
  • 跖骨间滑囊炎与亚临床滑膜炎(OR 3.4)和腱鞘炎(OR 5.9)相关。
  • 跖骨间滑囊炎预测关节炎发展(调整后HR 1.6),尤其在ACPA阳性者中(调整后HR 2.2)。

核心结论

  • 约四分之一的临床疑似关节痛患者存在跖骨间滑囊炎,且常伴随亚临床滑膜炎和腱鞘炎。
  • 跖骨间滑囊炎先于临床关节炎出现,尤其在ACPA阳性临床疑似关节痛患者中。
  • 这些结果强化了关节旁滑膜炎症参与类风湿关节炎最早发展阶段的观点。

研究设计与样本

  • 研究纳入577例连续临床疑似关节痛患者,行足前部、掌指关节和腕关节的增强MRI。
  • MRI按类风湿关节炎MRI评分系统评估亚临床滑膜炎、腱鞘炎和骨炎(合计为RAMRIS炎症),并评估跖骨间滑囊炎。
  • 跖骨间滑囊炎定义为在年龄匹配的无症状对照中同部位不常见(即大小评分高于第95百分位)。
  • 采用Cox回归评估跖骨间滑囊炎与中位25个月随访期间临床关节炎发展的关联,并进行ACPA分层分析。

主要发现

  • 临床疑似关节痛患者就诊时,23%存在跖骨间滑囊炎。
  • ACPA阳性临床疑似关节痛患者中跖骨间滑囊炎发生率高于ACPA阴性者(47% vs 19%,P < 0.001)。
  • 存在跖骨间滑囊炎的患者更可能同时有亚临床滑膜炎(OR 3.4,95% CI 1.8, 6.5)和腱鞘炎(OR 5.9,95% CI 2.8, 12.6)。
  • 跖骨间滑囊炎与关节炎发展风险升高相关(调整其他亚临床炎症后HR 1.6,95% CI 1.0-2.7)。
  • 跖骨间滑囊炎预测ACPA阳性临床疑似关节痛患者的关节炎发展(调整后HR 2.2,95% CI 1.0-4.7),但在ACPA阴性患者中无此预测作用(HR 0.8,95% CI 0.4-1.7)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Intermetatarsal bursitis (IMB) represents juxta-articular synovial inflammation of the intermetatarsal bursae. Recent MRI studies identified IMB as feature of early RA, but whether IMB already occurs in the pre-arthritic phase is unknown. We performed a large MRI study in clinically suspect arthralgia (CSA) to assess the occurrence and prognostic value of IMB. METHODS: A total of 577 consecutive CSA patients underwent contrast-enhanced MRI of the forefoot, metacarpophalangeal joints and wrist. MRIs were evaluated for subclinical synovitis/tenosynovitis/osteitis in line with the RA MRI scoring system (summed as RAMRIS inflammation) and for IMB. IMB was considered present if uncommon in the general population at the same location (i.e. size scored above the 95th percentile in age-matched symptom-free controls). The relation of IMB with other MRI-detected subclinical inflammation (synovitis/tenosynovitis/osteitis) was studied. Cox-regression assessed the association with clinical arthritis development during median 25 months follow-up. ACPA stratification was performed. RESULTS: At presentation with CSA, 23% had IMB. IMB was more frequent in ACPA-positive than ACPA-negative CSA (47% vs 19%, P < 0.001). Patients with IMB were more likely to also have subclinical synovitis [OR 3.4 (95% CI 1.8, 6.5)] and tenosynovitis [5.9(2.8, 12.6)]. IMB conferred higher risk of developing arthritis [HR 1.6(1.0-2.7) adjusted for other subclinical inflammation]. IMB-presence predicted arthritis development in ACPA-positive CSA [adjusted HR 2.2(1.0-4.7)], but not in ACPA-negative CSA-patients [0.8(0.4-1.7)]. CONCLUSION: Approximately a quarter of CSA patients have IMB, which is frequently accompanied by subclinical synovitis and tenosynovitis. IMB precedes development of clinical arthritis, particularly in ACPA-positive CSA. These results reinforce the notion that juxta-articular synovial inflammation is involved in the earliest phases of RA development.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. van Dijk BT, Wouters F, van Mulligen E, et al. During development of rheumatoid arthritis, intermetatarsal bursitis may occur before clinical joint swelling: a large imaging study in patients with clinically suspect arthralgia. Rheumatology (Oxford). 2022. PMID: 34791051. doi:10.1093/rheumatology/keab830

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。